The Efficacy of Citalopram Treatment in Acute Stroke "TALOS"


Phase 2 Results N/A

Summary of Purpose

We wish to conduct a prospective, randomized, double blind, placebo controlled multi center study of the combined neuroprotective and antithrombotic effects of SSRI treatment after stroke. Hypotheses: SSRI treatment commenced in the acute phase of stroke (day 0-7) protects against new thromboembolic events and leads to better rehabilitation. 600 stroke patients will be randomized in a 1:1 ratio. ...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 December 2014.

1 Sep 2013 3 Sep 2013 1 Jan 2016 1 Jul 2021 1 Dec 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment